Skip to main content
Top
Published in: Endocrine 2/2018

01-02-2018 | Original Article

Trends in surgery, hospital admissions and imaging for pituitary adenomas in Australia

Authors: Sjorjina Crowther, R. Louise Rushworth, Wayne Rankin, Henrik Falhammar, Liza K. Phillips, David J. Torpy

Published in: Endocrine | Issue 2/2018

Login to get access

Abstract

Purpose

There is a paucity of epidemiological information on treatment and imaging of pituitary adenomas in Australia.

Methods

Australian data on pituitary surgery, hospital admissions for pituitary adenomas, and pituitary imaging on patients 15 years and over were obtained from administrative databases between 2000/2001 and 2014/2015. Changes over time and by age and sex were assessed.

Results

In 2014/15 there were 37.7 pituitary procedures/million population, corresponding to a 35.4% (p < 0.05) increase over the 2000/2001 rate. Overall, most (87.2%) procedures were partial excisions of pituitary gland via transsphenoidal surgery (TSS). Admissions for acromegaly increased from 7.1/million in 2000/2001 to 17.2/million in 2003/2004 and then decreased to 6.5/million in 2014/2015. The average age-adjusted rate of pituitary imaging over the study period was 689.6/million/year, which increased significantly (p < 0.05). There was a significant increase in pituitary MRIs (p < 0.05) and a significant decline in pituitary CTs (p < 0.05). Surgical procedure rates were correlated with the pituitary imaging rates (r = 0.62, p < 0.05).

Conclusion

Pituitary surgery rates increased between 2000/2001 and 2014/2015. The most common procedure was partial excision of the pituitary gland via TSS. Admissions for pituitary neoplasms increased over the study while admissions for acromegaly rose to their highest rate in 2003/2004 and then decreased. There was a substantial increase in the rate of pituitary imaging, which may have resulted in increased detection of pituitary incidentalomas. The underlying reasons for the increased rate of pituitary surgery, and the non-sustained increased rate of admissions for acromegaly are unclear and warrant further investigation.
Literature
1.
go back to reference T.S. Surawicz, B.J. McCarthy, V. Kupelian, P.J. Jukich, J.M. Bruner, F.G. Davis, Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990–1994. Neuro. Oncol. 1(1), 14–25 (1999)CrossRefPubMedPubMedCentral T.S. Surawicz, B.J. McCarthy, V. Kupelian, P.J. Jukich, J.M. Bruner, F.G. Davis, Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990–1994. Neuro. Oncol. 1(1), 14–25 (1999)CrossRefPubMedPubMedCentral
2.
go back to reference A. Tjörnstrand, K. Gunnarsson, M. Evert, E. Holmberg, O. Ragnarsson, T. Rosen, H. Filipsson Nyström, The incidence rate of pituitary adenomas in western Sweden for the period of 2001–2011. Eur. J. Endocrinol. 171(4), 519–526 (2014) A. Tjörnstrand, K. Gunnarsson, M. Evert, E. Holmberg, O. Ragnarsson, T. Rosen, H. Filipsson Nyström, The incidence rate of pituitary adenomas in western Sweden for the period of 2001–2011. Eur. J. Endocrinol. 171(4), 519–526 (2014)
3.
go back to reference A. Raappaana, J. Koivukangas, T. Ebeling, T. Pirila, Incidence of pituitary adenomas in Northern Finland in 1992–2007. J. Clin. Endocrinol. Metab. 95(9), 4268–4275 (2010)CrossRef A. Raappaana, J. Koivukangas, T. Ebeling, T. Pirila, Incidence of pituitary adenomas in Northern Finland in 1992–2007. J. Clin. Endocrinol. Metab. 95(9), 4268–4275 (2010)CrossRef
4.
go back to reference A.F. Daly, M. Rixhon, C. Adam, A. Dempegioti, M.A. Tichomirowa, A. Beckers, High prevalence of pituitary adenomas: a cross sectional study in the province of Leige, Belgium. J. Clin. Endocrinol. Metab. 91(12), 4769–4775 (2006)CrossRefPubMed A.F. Daly, M. Rixhon, C. Adam, A. Dempegioti, M.A. Tichomirowa, A. Beckers, High prevalence of pituitary adenomas: a cross sectional study in the province of Leige, Belgium. J. Clin. Endocrinol. Metab. 91(12), 4769–4775 (2006)CrossRefPubMed
5.
go back to reference A. Fernandez, N. Karavitaki, J.A. Wass, Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin. Endocrinol. 72(3), 377–382 (2010)CrossRef A. Fernandez, N. Karavitaki, J.A. Wass, Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin. Endocrinol. 72(3), 377–382 (2010)CrossRef
6.
go back to reference B.M. Arafah, M.P. Nasrallah, Pituitary tumors: pathophysiology, clinical manifestations and management. Endocr. Relat. Cancer. 8, 287–305 (2001)CrossRefPubMed B.M. Arafah, M.P. Nasrallah, Pituitary tumors: pathophysiology, clinical manifestations and management. Endocr. Relat. Cancer. 8, 287–305 (2001)CrossRefPubMed
7.
go back to reference M.W. Vernooij, M.A. Ikram, H.L. Tanghe, A.J. Vincent, A. Hofman, G.P. Krestin, W.J. Niessen, M.M. Breteler, A. van der Lugt, Incidental findings on brain MRI in the general population. N. Engl. J. Med. 357, 1821–1828 (2007)CrossRefPubMed M.W. Vernooij, M.A. Ikram, H.L. Tanghe, A.J. Vincent, A. Hofman, G.P. Krestin, W.J. Niessen, M.M. Breteler, A. van der Lugt, Incidental findings on brain MRI in the general population. N. Engl. J. Med. 357, 1821–1828 (2007)CrossRefPubMed
8.
go back to reference S. Naoko, O. Ken’ichi, T. Shigeyuki, T. Akira, K. Yuzuru, A survey of pituitary incidentaloma in Japan. Eur. J. Endocrinol. 149, 123–127 (2003)CrossRef S. Naoko, O. Ken’ichi, T. Shigeyuki, T. Akira, K. Yuzuru, A survey of pituitary incidentaloma in Japan. Eur. J. Endocrinol. 149, 123–127 (2003)CrossRef
9.
go back to reference S. Berkmann, Intraoperative MRI and endocrinological outcome of transsphenoidal surgery for non-functioning pituitary adenoma. Acta Neurochir. 154, 639–647 (2012)CrossRefPubMed S. Berkmann, Intraoperative MRI and endocrinological outcome of transsphenoidal surgery for non-functioning pituitary adenoma. Acta Neurochir. 154, 639–647 (2012)CrossRefPubMed
10.
go back to reference P. Famini, M.M. Maya, S. Melmed, Pituitary magnetic resonance imaging for sellar and parasellar masses: ten year experience in 2598 patients. J. Clin. Endocrinol. Metab. 96(6), 1633–1641 (2011)CrossRefPubMedPubMedCentral P. Famini, M.M. Maya, S. Melmed, Pituitary magnetic resonance imaging for sellar and parasellar masses: ten year experience in 2598 patients. J. Clin. Endocrinol. Metab. 96(6), 1633–1641 (2011)CrossRefPubMedPubMedCentral
13.
go back to reference M.E. Molitch, Diagnosis and treatment of pituitary adenomas: a review. JAMA. 317(5), 516–524 (2017)CrossRefPubMed M.E. Molitch, Diagnosis and treatment of pituitary adenomas: a review. JAMA. 317(5), 516–524 (2017)CrossRefPubMed
14.
go back to reference M. Buchfelder., S.M. Schlaffer, The surgical treatment of acromegaly. Pituitary. 20(1), 76–83 (2017)CrossRefPubMed M. Buchfelder., S.M. Schlaffer, The surgical treatment of acromegaly. Pituitary. 20(1), 76–83 (2017)CrossRefPubMed
15.
go back to reference A. Giustina, P. Chanson, D. Kleinberg, M.D. Bronstein, D.R. Clemmons, A. Klibanski, A.K. van der Lely, C.J. Strasburger, S.W. Lamberts, K.K. Ho, F.F. Casanueva, S. Melmed, Expert consensus document: A consensus on the medical treatment of acromegaly. Nat. Rev. Endocrinol. 10(4), 243–248 (2014)CrossRefPubMed A. Giustina, P. Chanson, D. Kleinberg, M.D. Bronstein, D.R. Clemmons, A. Klibanski, A.K. van der Lely, C.J. Strasburger, S.W. Lamberts, K.K. Ho, F.F. Casanueva, S. Melmed, Expert consensus document: A consensus on the medical treatment of acromegaly. Nat. Rev. Endocrinol. 10(4), 243–248 (2014)CrossRefPubMed
16.
go back to reference M. Buchfelder, S. Schlaffer, Surgical treatment for pituitary tumours. Best. Pract. Res. Clin. Endocrinol. Metab. 23(5), 677–692 (2009)CrossRefPubMed M. Buchfelder, S. Schlaffer, Surgical treatment for pituitary tumours. Best. Pract. Res. Clin. Endocrinol. Metab. 23(5), 677–692 (2009)CrossRefPubMed
17.
go back to reference W.T. Couldwell, Transsphenoidal and transcranial surgery for pituitary adenomas. J. Neurooncol. 69(1–3), 237–256 (2004)CrossRefPubMed W.T. Couldwell, Transsphenoidal and transcranial surgery for pituitary adenomas. J. Neurooncol. 69(1–3), 237–256 (2004)CrossRefPubMed
18.
go back to reference M. Ammirati, L. Wei, I. Ciric, Short-term outcome of endoscopic versus microscopic pituitary adenoma surgery: a systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatr. 84(8), 843–849 (2012)CrossRef M. Ammirati, L. Wei, I. Ciric, Short-term outcome of endoscopic versus microscopic pituitary adenoma surgery: a systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatr. 84(8), 843–849 (2012)CrossRef
19.
go back to reference E. De Divitilis, Endoscopic transphenoidal surgery: stone-in-the-pond effect. Neurosurgery. 59(3), 512–520 (2006)CrossRef E. De Divitilis, Endoscopic transphenoidal surgery: stone-in-the-pond effect. Neurosurgery. 59(3), 512–520 (2006)CrossRef
20.
go back to reference M.A. Wagenmaker, H.D. Boogaarts, S.H. Roerink, H.J. Timmers, N.M. Stikkelbroeck, J.W. Smit, E.J. van Lindert, R.T. Netea-Maier, J.A. Grotenhuis, A.R. Hermus, Endoscopic transsphenoidal pituitary surgery: a good and safe primary treatment option for Cushing’s disease, even in case of macroadenomas or invasive adenomas. Eur. J. Endocrinol. 169(3), 329–337 (2013)CrossRef M.A. Wagenmaker, H.D. Boogaarts, S.H. Roerink, H.J. Timmers, N.M. Stikkelbroeck, J.W. Smit, E.J. van Lindert, R.T. Netea-Maier, J.A. Grotenhuis, A.R. Hermus, Endoscopic transsphenoidal pituitary surgery: a good and safe primary treatment option for Cushing’s disease, even in case of macroadenomas or invasive adenomas. Eur. J. Endocrinol. 169(3), 329–337 (2013)CrossRef
21.
go back to reference E.A.C. Pereira, P. Plaha, A. Charia, M. Paranathala, N. Haslam, A. Rogers, T. Korevaar, D. Tran, R. Olarinde, N. Karavitaki, A.B. Grossman, S.A. Cudlip, Transsphenoidal pituitary surgery in the elderly is safe and effective. B.J. Neurosurgery. 28(5), 616–621 (2014)CrossRef E.A.C. Pereira, P. Plaha, A. Charia, M. Paranathala, N. Haslam, A. Rogers, T. Korevaar, D. Tran, R. Olarinde, N. Karavitaki, A.B. Grossman, S.A. Cudlip, Transsphenoidal pituitary surgery in the elderly is safe and effective. B.J. Neurosurgery. 28(5), 616–621 (2014)CrossRef
22.
go back to reference E. Ritvonen, A. Karppinen, H. Sintonen, S. Vehkavaara, L. Kivipelto, R.P. Roine, M. Niemelä, C. Schalin-Jäntti: Normal long-term health-related quality of life can be achieved in patients with functional pituitary adenomas having surgery as primary treatment. Clin. Endocrinol. (2014) https://doi.org/10.1111/cen.12550 E. Ritvonen, A. Karppinen, H. Sintonen, S. Vehkavaara, L. Kivipelto, R.P. Roine, M. Niemelä, C. Schalin-Jäntti: Normal long-term health-related quality of life can be achieved in patients with functional pituitary adenomas having surgery as primary treatment. Clin. Endocrinol. (2014) https://​doi.​org/​10.​1111/​cen.​12550
23.
go back to reference L.A. Zimmer, O. Shah, P.V. Theodosopoulus, Short-term quality-of-life changes after endoscopic pituitary surgery rated with SNOT-22. J. Neurol. Surg. B. Skull. Base 75(4), 288–292 (2014)CrossRefPubMedPubMedCentral L.A. Zimmer, O. Shah, P.V. Theodosopoulus, Short-term quality-of-life changes after endoscopic pituitary surgery rated with SNOT-22. J. Neurol. Surg. B. Skull. Base 75(4), 288–292 (2014)CrossRefPubMedPubMedCentral
24.
go back to reference J.A. Villwock, M. Villwock, E. Deshaies, P. Goyal, Significant increases of pituitary tumors and resections from 1993 to 2011. Int. Forum. Allergy. Rhinol. 4, 767–770 (2014)CrossRefPubMed J.A. Villwock, M. Villwock, E. Deshaies, P. Goyal, Significant increases of pituitary tumors and resections from 1993 to 2011. Int. Forum. Allergy. Rhinol. 4, 767–770 (2014)CrossRefPubMed
25.
go back to reference P. Cappabianca, M. Cavallo, A. Colao, E. de Divitiis, Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas. J. Neurosurg. 97(2), 293–298 (2002)CrossRefPubMed P. Cappabianca, M. Cavallo, A. Colao, E. de Divitiis, Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas. J. Neurosurg. 97(2), 293–298 (2002)CrossRefPubMed
26.
go back to reference H. Singh, W.I. Essayed, A. Cohen-Gadol, G. Zada, T.H. Schwartz, Resection of pituitary tumours: endoscopic versus microscopic. J. Neurooncol. 130(2), 309–317 (2016)CrossRefPubMed H. Singh, W.I. Essayed, A. Cohen-Gadol, G. Zada, T.H. Schwartz, Resection of pituitary tumours: endoscopic versus microscopic. J. Neurooncol. 130(2), 309–317 (2016)CrossRefPubMed
27.
go back to reference National Centre for Classification in Health (NCCH). The Australian Classification of Health Interventions (ACHI) -Seventh Edition - Tabular list of interventions and Alphabetic index of interventions. (NCCH, Faculty of Health Sciences, The University of Sydney, Sydney), 2010) National Centre for Classification in Health (NCCH). The Australian Classification of Health Interventions (ACHI) -Seventh Edition - Tabular list of interventions and Alphabetic index of interventions. (NCCH, Faculty of Health Sciences, The University of Sydney, Sydney), 2010)
28.
go back to reference Australian Institute of Health and Welfare (AIHW). Admitted patient care 2013–14: Australian hospital statistics. (AIHW, Canberra), 2015). Health services series no. 60. Cat. no. HSE156 Australian Institute of Health and Welfare (AIHW). Admitted patient care 2013–14: Australian hospital statistics. (AIHW, Canberra), 2015). Health services series no. 60. Cat. no. HSE156
30.
go back to reference P.U. Freda, A.M. Beckers, L. Katznelson, M.E. Molitch, V.M. Montori, PostKD., M.L. Vance, Pituitary incidentaloma: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 96(4), 894–904 (2011)CrossRefPubMedPubMedCentral P.U. Freda, A.M. Beckers, L. Katznelson, M.E. Molitch, V.M. Montori, PostKD., M.L. Vance, Pituitary incidentaloma: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 96(4), 894–904 (2011)CrossRefPubMedPubMedCentral
31.
go back to reference J. Rennet, A. Doerfler, Imaging of sellar and parasellar lesions. Clin. Neurol. Neurosurg. 109, 111–124 (2007)CrossRef J. Rennet, A. Doerfler, Imaging of sellar and parasellar lesions. Clin. Neurol. Neurosurg. 109, 111–124 (2007)CrossRef
32.
33.
go back to reference S. Ezzat, S.L. Asa, W.T. Couldwell, C.E. Barr, W.E. Dodge, M.L. Vance, I.E. McCutcheon, The prevalence of pituitary adenomas: a systematic review. Cancer. 101, 613–619 (2004)CrossRefPubMed S. Ezzat, S.L. Asa, W.T. Couldwell, C.E. Barr, W.E. Dodge, M.L. Vance, I.E. McCutcheon, The prevalence of pituitary adenomas: a systematic review. Cancer. 101, 613–619 (2004)CrossRefPubMed
34.
go back to reference N. Karavitaki, K. Collison, J. Halliday, J.V. Byrne, P. Price, S. Cudlip, J.A.H. Wass, What is the natural history of nonoperated nonfunctioning pituitary adenomas? Clin. Endocrinol. 67(6), 938–943 (2007)CrossRef N. Karavitaki, K. Collison, J. Halliday, J.V. Byrne, P. Price, S. Cudlip, J.A.H. Wass, What is the natural history of nonoperated nonfunctioning pituitary adenomas? Clin. Endocrinol. 67(6), 938–943 (2007)CrossRef
35.
go back to reference M. Gruppetta, C. Mercieca, J. Vassallo, Prevalence and incidence of pituitary adenomas: a population based study in Malta. Pituitary. 16(4), 545–553 (2013)CrossRefPubMed M. Gruppetta, C. Mercieca, J. Vassallo, Prevalence and incidence of pituitary adenomas: a population based study in Malta. Pituitary. 16(4), 545–553 (2013)CrossRefPubMed
36.
go back to reference E. Leifke, V. Gorenoi, C. Wichers, A. Von Zur Muhlen, E. Von Buren, G. Brabant, Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohort. Clin. Endocrinol. 53(6), 689–695 (2000)CrossRef E. Leifke, V. Gorenoi, C. Wichers, A. Von Zur Muhlen, E. Von Buren, G. Brabant, Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohort. Clin. Endocrinol. 53(6), 689–695 (2000)CrossRef
37.
go back to reference A. Giustina, A. Barkan, F.F. Casanueva, F. Cavagnini, L. Frohman, K. Ho, J. Veldhuis, J. Wass, K. Von Werder, S. Melmed, Criteria for cure of acromegaly: a consensus statement. J. Clin. Endocrinol. Metab. 85(2), 526–529 (2000)PubMed A. Giustina, A. Barkan, F.F. Casanueva, F. Cavagnini, L. Frohman, K. Ho, J. Veldhuis, J. Wass, K. Von Werder, S. Melmed, Criteria for cure of acromegaly: a consensus statement. J. Clin. Endocrinol. Metab. 85(2), 526–529 (2000)PubMed
38.
go back to reference M.W. Elmlinger, W. Kühnel, M.M. Weber, M.B. Ranke, Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3). Clin. Chem. Lab. Med. 42(6), 654–664 (2004)CrossRefPubMed M.W. Elmlinger, W. Kühnel, M.M. Weber, M.B. Ranke, Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3). Clin. Chem. Lab. Med. 42(6), 654–664 (2004)CrossRefPubMed
39.
go back to reference A. Algeciras-Schimnich, D.E. Bruns, J.C. Boyd, S.C. Bryant, K.A. La Fortune, S.K. Grebe, Failure of current laboratory protocols to detect lot-to-lot reagent differences: findings and possible solutions. Clin. Chem. 59(8), 1187–1194 (2013)CrossRefPubMed A. Algeciras-Schimnich, D.E. Bruns, J.C. Boyd, S.C. Bryant, K.A. La Fortune, S.K. Grebe, Failure of current laboratory protocols to detect lot-to-lot reagent differences: findings and possible solutions. Clin. Chem. 59(8), 1187–1194 (2013)CrossRefPubMed
40.
go back to reference M.S. Broder, E. Change, D. Cherepanov, M.P. Neary, W.H. Ludlam, Incidence and prevalence of acromegaly in the United States: A Claims-Bsed Analysis. Endocr. Pract. 22(11), 1327–1335 (2016)CrossRefPubMed M.S. Broder, E. Change, D. Cherepanov, M.P. Neary, W.H. Ludlam, Incidence and prevalence of acromegaly in the United States: A Claims-Bsed Analysis. Endocr. Pract. 22(11), 1327–1335 (2016)CrossRefPubMed
41.
go back to reference E. Lesén, D. Granfeldt, A. Houchard, J. Dinet, A. Berthon, D.S. Olsson, I. Björholt, G. Johannsson, Comorbidities, treatment patterns and cost-of-illness of acromegaly in Sweden: a register-linkage population-based study. Eur. J. Endocrinol. 176(2), 203–212 (2017)CrossRefPubMed E. Lesén, D. Granfeldt, A. Houchard, J. Dinet, A. Berthon, D.S. Olsson, I. Björholt, G. Johannsson, Comorbidities, treatment patterns and cost-of-illness of acromegaly in Sweden: a register-linkage population-based study. Eur. J. Endocrinol. 176(2), 203–212 (2017)CrossRefPubMed
Metadata
Title
Trends in surgery, hospital admissions and imaging for pituitary adenomas in Australia
Authors
Sjorjina Crowther
R. Louise Rushworth
Wayne Rankin
Henrik Falhammar
Liza K. Phillips
David J. Torpy
Publication date
01-02-2018
Publisher
Springer US
Published in
Endocrine / Issue 2/2018
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-017-1457-4

Other articles of this Issue 2/2018

Endocrine 2/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.